Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

61336-70-7Amoxicillin Trihydrate Working Standard (Secondary Reference Standard)

● Under Development

Katalog-Nr.::	VL1970029
CAS-Nr.::	61336-70-7
Summenformel::	C16H25N3O8S
Molare Masse::	419.45 g/mol

Wie können wir helfen?

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 61336-70-7

Parent drug

Amoxicillin / Amoxicillin Trihydrate

IUPAC-Name

(2S,5R,6R)-6-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

SMILES

O=C1[C@H]([C@@]2(N1[C@H](C(C)(S2)C)C(O)=O)[H])NC([C@@H](C3=CC=C(C=C3)O)N)=O.[3H2O]

InChI

InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1

Synonyme

N/A

Beschreibung

Amoxicillin Trihydrate Working Standard (Secondary Reference Standard), CAS 61336-70-7, is a characterized material supplied with certified assay, impurity profile, and traceability to internal primary standards to support analytical method calibration and validation. Supplied with a certificate of analysis reporting potency, related substances, water content, and storage conditions, the working standard is produced under controlled conditions and accompanied by lot-specific data for reproducible results. It is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. Store and handle per provided specifications to maintain integrity.

References

Bittner, L. K. H., et al. Near-Infrared Reflection Spectroscopy (NIRS) as a Successful Tool for Simultaneous Identification and Particle Size Determination of Amoxicillin Trihydrate.â€ Journal of Pharmaceutical and Biomedical Analysis, vol. 54, no. 5, Apr. 2011, pp. 1059â€“64, https://doi.org/10.1016/j.jpba.2010.12.019.?